机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.West China School of medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.四川大学华西医院[2]Ningbo Diagnostic Pathology Center, Ningbo City, Zhejiang Province, China.[3]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, PR China.
Luzhou City Science and
Technology Bureau (grant number 2021LZXNYDJ10 and
2020LZXNYDJ14), Cooperation Project between the Second People's Hospital of Deyang and Southwest Medical University
(2022DYEXNYD002).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|3 区医学
小类|3 区外科
最新[2023]版:
大类|3 区医学
小类|3 区外科
第一作者:
第一作者机构:[1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.West China School of medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.
共同第一作者:
通讯作者:
通讯机构:[3]Department of Rehabilitation, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, PR China.[*1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Guoxue Xiang #37, Chengdu, 610041, Sichuan, China.
推荐引用方式(GB/T 7714):
Wang Jie,Xiao Yuhan,Yu Qingxin,et al.KRT72 might serves as a prognostic biomarker for patients with prostate cancer[J].Asian journal of surgery.2023,doi:10.1016/j.asjsur.2023.07.097.
APA:
Wang Jie,Xiao Yuhan,Yu Qingxin&Zhang Chi.(2023).KRT72 might serves as a prognostic biomarker for patients with prostate cancer.Asian journal of surgery,,
MLA:
Wang Jie,et al."KRT72 might serves as a prognostic biomarker for patients with prostate cancer".Asian journal of surgery .(2023)